If you or a loved one took the prescription drug Elmiron (pentosan polysulfate sodium) for at least two years and after using the drug began to suffer serious vision problems, you may be eligible to join an Elmiron class-action lawsuit.
A federal class-action lawsuit was filed in October 2020 alleging Janssen Pharmaceuticals failed to warn doctors and patients that the drug could cause pigmentary maculopathy. Janssen added a warning in June of 2020, but thousands of users of the drug may already have had toxic levels of exposure.
Some 130 cases from across the United States have already been consolidated into a class-action lawsuit. If you believe you suffered eye damage as a result of using Elmiron, talk with one of our trial attorneys to see if you meet the criteria for joining the lawsuit. Call 800-TedLyon. We represent clients throughout the United States.
Elmiron (generic name: pentosan polysulfate sodium) is a drug used to treat interstitial cystitis (IC), a chronic, often painful and debilitating bladder condition that affects as many as 12 million Americans.
Elmiron is the only medication approved by the FDA to treat this condition and its users typically take it several times a day to prevent irritation and swelling of the walls of the bladder. For most users of the drug it was a godsend, but between 1997 and 2020 hundreds of people filed reports with the FDA claiming the drug had caused serious vision problems. More than 100 people filed lawsuits.
And yet Janssen Pharmaceuticals did not change its warning label in the U.S. until 2020. (It changed the warning label in Canada in 2019).
The new warning label states that Elmiron can cause pigmentary changes in the retina accompanied by visual symptoms and cautions patients to have ophthalmologic examination prior to starting Elmiron and periodically while they are receiving treatment.
You may qualify to become part of the Elmiron class-action lawsuit if:
If you are experiencing vision problems but have not yet seen a doctor for a diagnosis, make an appointment to get examined by an ophthalmologist – a medical doctor who specializes in eyes - not an optometrist. The eye doctor will look for signs of abnormal blood vessels around the macula or dark spots near the retina.
Tell the doctor that you have used Elmiron and are concerned about maculopathy so they will do a thorough exam.
When you call and speak with one of our class-action attorneys, tell them your diagnosis, the treatment options your doctor has prescribed, and your doctor's prediction of future improvement. Tell us about how your daily life and work has been affected, and how it has impacted you and your family members.
All of this information will help us determine if you qualify to be part of the Elmiron lawsuit and your case for financial recovery.
© 2021 by Ted B. Lyon & Associates. All rights reserved.